BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 7, 2015
View Archived Issues
ADA highlights: ultra-long acting GLP-1/glucagon agonists for type 2 diabetes and obesity
Read More
Novel inhibitor of Plasmodium protein synthesis shows promise for malaria
Read More
Prism Pharma begins phase I/II study of C-82 topical gel
Read More
Five Prime Therapeutics begins phase I/II trial of FPA-008
Read More
Japanese team discloses Wnt signaling pathway inhibitors
Read More
Baxter spin-off Baxalta now in business
Read More
Versartis confirms removal of FDA partial hold on VRS-317 trial
Read More
Bristol-Myers Squibb patents TYK2 inhibitors
Read More
Lycera describes F1F0-ATPase inhibitors
Read More
Almirall reports JAK inhibitors
Read More
Quanticel Pharmaceuticals reports development of KDM1A inhibitors
Read More
Chong Kun Dang Holdings divulges HDAC6 inhibitors
Read More
[18F]AZC2, a novel PET probe for c-MET imaging
Read More
Scaffolds based on synthetic TCP and autologous cells for maxillofacial surgery
Read More
Strensiq receives first approval in Japan for hypophosphatasia
Read More
CAT-1004 receives FDA fast track designation for Duchenne muscular dystrophy
Read More
Novel PI3Kdelta inhibitor shows promise for the treatment of EBA
Read More
MD Anderson Cancer Center starts phase I trial of siRNA targeting EphA2
Read More
NIDA tests AZD-8529 for smoking cessation
Read More
Janssen opens daratumumab expanded access program in U.S.
Read More
FDA clears Celtaxsys to begin phase II trial of acebilustat for cystic fibrosis
Read More
Olanedine antiseptic approved in Japan
Read More
JNJ-42165279 enters phase II trial in social anxiety disorder
Read More
Ignyta collaborates with UCSF on proof-of-concept trial of entrectinib in metastatic melanoma
Read More
Celtic Biotech and Emory University agree to develop crotamine-based imaging agent
Read More
Celsion releases new interim data from DIGNITY breast cancer study of ThermoDox
Read More